Article
FTC effort to stop Amgen's Horizon takeover faces uphill fight
Rating:
0.0
Views:
73
Likes:
1
Library:
1
The Federal Trade Commission (FTC) faces an uphill battle in its fight against Amgen Inc's $27.8 billion acquisition of Horizon Therapeutics with an untested argument before a Trump-appointed judge, three antitrust experts said.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value